The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Prednisolone 5 mg soluble tablets



Amdipharm LimitedPA1142/034/001

Main Information

Trade NamePrednisolone 5 mg soluble tablets
Active SubstancesPrednisolone
Dosage FormSoluble tablet
Licence HolderAmdipharm Limited
Licence NumberPA1142/034/001

Group Information

ATC CodeH02AB Glucocorticoids
H02AB06 prednisolone

Status

License statusAuthorised
Licence Issued14/11/2014
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back